Senior Director, DMPK
Cogent Biosciences Inc - Boulder, Colorado, United States
Posted Nov 17, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Offered From the posting source checked Nov 18, 2026
- Verification
- Not verified checked Nov 20, 2026
- Salary
- $255K-$290K From the posting source checked Nov 18, 2026
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Role
- Seniority
- Director Plus From the posting source checked Nov 18, 2026
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 18, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Senior Director, DMPK Boulder, Colorado, United States Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing. The Role: The Senior Director, DMPK is responsible for providing scientific and strategic leadership for Drug Metabolism and Pharmacokinetics activities across Cogent's discovery and development portfolio. This individual will lead the DMPK function and develop and execute DMPK strategies that support small molecule programs from early discovery through candidate selection, IND-enabling studies, and clinical development. The successful candidate will bring deep expertise in ADME, pharmacokinetics, bioanalysis, and translational DMPK and will work closely with Medicinal Chemistry, Biology, Pharmacology, Toxicology, Clinical Pharmacology, and other cross-functional partners. This role will lead an internal DMPK team and oversee external CROs and partners to ensure high-quality data and timely execution of program objectives. The ideal candidate is a highly collaborative scientific leader
Read the full description at job-boards.greenhouse.io. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Senior Director, DMPK
Vertex Pharmaceuticals - San Diego, CA
Senior Scientist (Drug Metabolism & Pharmacokinetics)
Genentech, Inc. - South San Francisco, California, United States of America
Principal Scientist, Computational Chemistry
Cogent Biosciences Inc - Boulder, Colorado, United States
Director / Senior Director, DMPK
Formation Bio - Boston, MA; New York, NY